|Chemical and physical data|
|Molar mass||405.614 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
Minaxolone (CCI-12923) is a neuroactive steroid which was developed as a general anesthetic but was withdrawn before registration due to toxicity seen with long-term administration in rats, and hence was never marketed. It is a positive allosteric modulator of the GABAA receptor, as well as, less potently, a positive allosteric modulator of the glycine receptor.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|